Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03296852 · ClinicalTrials.gov registry record · Early Phase 1

Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke

A Early Phase 1 study, sponsored by University of California, Los Angeles.

Completed
Registry status
Early Phase 1
Development phase
12
Enrollment target

NCT03296852 is a Early Phase 1 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03296852, a Early Phase 1 study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Early Phase 1
Development phase
12 participants
Enrollment target

Study Summary

The purpose of this research study is to test a new medical device, called SONAS. The SONAS device is a portable, battery-powered ultrasound device to detect strokes in the prehospital environment, such as emergency vehicles (eg. ambulances, helicopters). To demonstrate the safety of the device the goal is test it in a small number of healthy volunteers first. The SONAS device will be used to detect changes in blood flow to the brain through ultrasound, otherwise known as TransCranial Doppler (TCD). To date, the SONAS device has been tested extensively in the laboratory, in animals and in human cadavers. The purpose of the present study is to test the device for safety and efficacy in a small group of healthy volunteers. This study will test the device on 10 healthy volunteers. Each volunteer will have a physical examination, neurological examination, and brain MRI both before and after the TCD test is performed. All of these study procedures will be performed on 1 visit, lasting approximately 5 hours. The brain MRI's will be used to verify the effectiveness of the SONAS device on detecting changes in blood flow to the brain.

Interventions

  • DRUG Lumason
  • DIAGNOSTIC_TEST SONAS Ultrasound Device

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-04-19
Est. Completion 2019-01-20
Phase Early Phase 1

What the Registry Record Tells You About NCT03296852

The ClinicalTrials.gov registry entry for NCT03296852 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Lumason is the first listed.

NCT03296852 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03296852 about?

NCT03296852 is a clinical study titled "Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke". The purpose of this research study is to test a new medical device, called SONAS. The SONAS device is a portable, battery-powered ultrasound device to detect strokes in the prehospital environment, such as emergency vehicles (eg. ambulances, helicopters). To demonstrate the safety of the device the ...

What is the current status of trial NCT03296852?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2018-04-19. Estimated completion is 2019-01-20.

What interventions are being tested in trial NCT03296852?

The interventions under investigation include: Lumason (DRUG), SONAS Ultrasound Device (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03296852?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.